当前位置:首页 - 行情中心 - 仁和药业(000650) - 财务分析 - 现金流量表

仁和药业

(000650)

  

流通市值:68.30亿  总市值:71.82亿
流通股本:13.31亿   总股本:14.00亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,946,800,100.462,158,782,109.89893,568,477.914,231,975,509.28
  收到的税费返还4,803,130.794,713,123.951,633.95-
  收到其他与经营活动有关的现金30,893,699.8718,574,637.4811,674,394.66114,386,672.14
  经营活动现金流入小计2,982,496,931.122,182,069,871.32905,244,506.524,346,362,181.42
  购买商品、接受劳务支付的现金1,780,410,697.811,044,523,732.86530,025,908.332,461,083,405.58
  支付给职工以及为职工支付的现金357,957,255.72264,223,146.14160,636,569.49497,902,079.93
  支付的各项税费283,067,746.68205,843,720.4643,659,264.25354,244,479.95
  支付其他与经营活动有关的现金143,040,468.7295,055,092.3746,369,106.83181,820,216.06
  经营活动现金流出小计2,564,476,168.931,609,645,691.83780,690,848.93,495,050,181.52
  经营活动产生的现金流量净额418,020,762.19572,424,179.49124,553,657.62851,311,999.9
二、投资活动产生的现金流量:
  收回投资收到的现金8,367,379,756.055,315,827,758.952,849,258,339.0711,834,967,400.68
  取得投资收益收到的现金51,597,990.2134,919,733.4119,078,949.78114,414,815.21
  处置固定资产、无形资产和其他长期资产收回的现金净额6,303.275,763.275,750360,236.15
  投资活动现金流入小计8,418,984,049.535,350,753,255.632,868,343,038.8511,949,742,452.04
  购建固定资产、无形资产和其他长期资产支付的现金29,376,495.3421,048,483.1418,641,157.8674,587,219.13
  投资支付的现金10,184,320,769.717,243,952,234.164,737,531,289.4511,973,376,888.59
  取得子公司及其他营业单位支付的现金-0-63,489.26
  投资活动现金流出小计10,213,697,265.057,265,000,717.34,756,172,447.3112,048,027,596.98
  投资活动产生的现金流量净额-1,794,713,215.52-1,914,247,461.67-1,887,829,408.46-98,285,144.94
三、筹资活动产生的现金流量:
  吸收投资收到的现金80,000-080,000
  其中:子公司吸收少数股东投资收到的现金80,000-080,000
  取得借款收到的现金--0-
  收到其他与筹资活动有关的现金2,353,137.15-02,325,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计2,433,137.15-02,405,000
  偿还债务支付的现金--0-
  分配股利、利润或偿付利息支付的现金211,714,555.771,382,665.910306,106,206.24
  其中:子公司支付给少数股东的股利、利润1,724,321.241,382,665.91095,623,262.84
  支付其他与筹资活动有关的现金100,392,369.0195,239,885.470918,992.42
  筹资活动现金流出小计312,106,924.7896,622,551.380307,025,198.66
  筹资活动产生的现金流量净额-309,673,787.63-96,622,551.380-304,620,198.66
四、汇率变动对现金及现金等价物的影响-45,889.74-35,537.68-20,777.29-9,950.5
五、现金及现金等价物净增加额-1,686,412,130.7-1,438,481,371.24-1,763,296,528.13448,396,705.8
  加:期初现金及现金等价物余额2,773,961,378.542,773,961,378.542,773,961,378.542,325,564,672.74
  期末现金及现金等价物余额1,087,549,247.841,335,480,007.31,010,664,850.412,773,961,378.54
补充资料:
  净利润-355,382,564.49-487,656,749.45
  资产减值准备-169,209.19-129,175,268.45
  固定资产和投资性房地产折旧-51,283,671.73-100,603,259.87
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-51,283,671.73-100,603,259.87
  无形资产摊销-6,902,360.36-14,615,618.05
  长期待摊费用摊销-1,070,710.34-3,372,841.37
  处置固定资产、无形资产和其他长期资产的损失-41,579.62--2,048,182.02
  固定资产报废损失-4,615.67-407,460.75
  公允价值变动损失--29,539,733.37--25,116,621.86
  财务费用-35,006.92-90,869.76
  投资损失--15,330,658.7--83,430,024.12
  递延所得税-3,175,494.95-306,297.07
  其中:递延所得税资产减少-3,186,325.88-410,567.3
    递延所得税负债增加--10,830.93--104,270.23
  存货的减少-222,685,123.8--49,230,030.81
  经营性应收项目的减少--177,281,129.26-178,959,085.45
  经营性应付项目的增加-145,766,640.12-78,307,579.87
  其他-0--15,529,062.5
  现金的期末余额-1,335,480,007.3-2,773,961,378.54
  减:现金的期初余额-2,773,961,378.54-2,325,564,672.74
  现金及现金等价物的净增加额--1,438,481,371.24-448,396,705.8
公告日期2026-10-272026-08-262026-04-282026-04-24
审计意见(境内)标准无保留意见
TOP↑